Provided by Tiger Trade Technology Pte. Ltd.

Sana Biotechnology, Inc.

3.91
+0.17004.55%
Post-market: 3.86-0.0500-1.28%19:54 EDT
Volume:2.93M
Turnover:11.55M
Market Cap:1.17B
PE:-5.12
High:4.10
Open:3.78
Low:3.74
Close:3.74
52wk High:6.55
52wk Low:2.61
Shares:299.00M
Float Shares:191.00M
Volume Ratio:0.91
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7636
EPS(LYR):-0.9642
ROE:-152.87%
ROA:-29.16%
PB:7.56
PE(LYR):-4.06

Loading ...

Sana announces follow-up results from first-in-human study transplanting UP421

TIPRANKS
·
Mar 13

Sana reports positive 14-month results from UP421 hypoimmune islet transplant study in type 1 diabetes

Reuters
·
Mar 13

Sana Biotechnology Inc - Hip-Modified Islets Show Safety, Immune Evasion, and Insulin Production at 14 Months

THOMSON REUTERS
·
Mar 13

Sana Biotechnology Inc - No Safety Issues Identified in up421 Islet Cell Study

THOMSON REUTERS
·
Mar 13

Sana Biotechnology Inc - Expects to File Ind and Initiate Phase 1 Trial for Sc451 This Year

THOMSON REUTERS
·
Mar 13

Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating

TIPRANKS
·
Mar 07

Stock Track | Sana Biotechnology Plummets 5.24% Intraday on AI Adoption Risk Disclosure

Stock Track
·
Mar 05

AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks

TIPRANKS
·
Mar 05

Stock Track | Sana Biotechnology Plummets 5.09% Intraday After H.C. Wainwright Cuts Price Target

Stock Track
·
Mar 04

Sana Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating

TIPRANKS
·
Mar 04

Sana Biotechnology, Inc. : H.c. Wainwright Cuts Target Price to $7 From $9

THOMSON REUTERS
·
Mar 04

BRIEF-Sana Biotechnology Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
Mar 04

Sana Biotechnology Q4 adjusted EPS misses estimates

Reuters
·
Mar 04

Sana Biotechnology Updates ATM Program to Support Development

TIPRANKS
·
Mar 04

Sana Biotechnology Q4 Adj. EPS $(0.16) Misses $(0.13) Estimate

Benzinga Earnings
·
Mar 04

Sana posts FY 2025 non-cash impairment of long-lived assets of USD 44.6 million, up 2,247.4%

Reuters
·
Mar 04

BRIEF-Sana Biotechnology Q4 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.13

Reuters
·
Mar 04

Sana Biotechnology Q4 Adjusted Net Income USD -44.736 Million VS. Ibes Estimate USD -34.3 Million

THOMSON REUTERS
·
Mar 04

Sana Biotechnology Q4 EPS USD -0.21

THOMSON REUTERS
·
Mar 04